FundRx

FundRx is a venture capital firm based in New York, specializing in funding biotechnology and healthcare startups that focus on innovative solutions aimed at addressing critical health challenges. FundRx, established in 2015, operates from its headquarters in New York, US. The firm engages in venture capital investments that support startups in the biotechnology and healthcare sectors. In November 2017, the company received investment from NRD Capital, marking a significant milestone in its funding journey.

FundRx specializes in venture capital investment focused on biotechnology and healthcare startups that aim to address the fundamental causes of illness. The company supports a diverse portfolio of innovations in sectors including precision health testing and medication management. Their core offerings encompass solutions like cloud infrastructure for computational chemistry and advanced laboratory automation technologies. End users include healthcare providers and research institutions that benefit from enhanced healthcare delivery and treatment options.

FundRx generates revenue primarily through strategic partnerships and investments in startups, allowing the firm to participate in the financial growth of these businesses. Transactions typically occur via equity stakes in the companies they support, ensuring a continuous demand for healthcare solutions offered by their partners, particularly in hospitals and clinics as they scale and reach market viability. FundRx aims to leverage its recent investment from NRD Capital in November 2017 to expand its portfolio of healthcare solutions. The firm is actively designing new products in precision health and is targeting expansion into markets in Latin America and regions with significant healthcare challenges by the end of 2023.